$ALAB

Astera Labs Inc (ALAB) Q3 2026 Earnings Call Highlights: Record Revenue Surge and Scorpio's

Astera Labs (ALAB) reported record Q3 2026 revenue, with executives discussing growth drivers like Scorpio X, Orion racks, and optical products. Key highlights include 10+ Scorpio X engagements, $100,000 content per Orion rack, and 30% long-term OpEx/revenue target. Revenue from new products expected in 2027-2029.

Original reporting
Published Nov 4, 2026, 7:09 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 7:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Astera Labs Inc (ALAB) Q3 2026 Earnings Call Highlights: Record Revenue Surge and Scorpio's — source image
Decision brief

The 30-second read

$ALABBullishMed
01

Why it matters

The disclosed numbers and roadmap provide fresh data for valuation models and sector positioning.

02

Market read

Astera's strong quarterly performance and detailed guidance could lift its stock and influence related AI‑hardware peers.

03

What to watch

High OpEx growth and headcount hiring could pressure cash flow in the near term.

Relevance 7/10Novelty 6/10Timing: post-earnings today

Background

Astera Labs held its Q3 2026 earnings call, revealing record revenue, detailed product pricing, and operating expense outlook.

Company-level read

Ticker impact

$ALABBullishHigh confidence
Context

Q3 earnings call disclosed record revenue growth, $162M OpEx, and detailed product content pricing, providing fresh guidance for Astera Labs.

Expected impact

likely upward pressure as investors price in strong revenue and clarified margin path.

Evidence & confidence

First report of quarterly results and guidance; material numbers and product roadmap are new.

Market effects

Strengthens outlook for AI‑infrastructure and data‑center hardware sector.

U.S. tech equities may benefit from Astera's positive guidance.

Highlights demand for high‑performance compute racks worldwide.

Counterpoint

Margin expansion may be slower than projected if software royalty uptake lags.

Key entities

  • Sanjay Gajendra

    President and COO, provided product and margin commentary.

  • Jitendra Mohan

    CEO, discussed content pricing and growth engines.

  • Desmond Lynch

    CFO, disclosed Q3 OpEx of $162M and future expense guidance.

Related articles

$ALABMedAI 8/10

Astera Labs (ALAB) Q3 2026 Earnings Call Transcript

Astera Labs (ALAB) reported Q3 2026 revenue of $584.9M, up 49% sequentially and 154% YoY. Growth was driven by the Scorpio X-Series, which surpassed P-Series in revenue. The company launched new products, including Aries 7 and Leo 2, and expanded its customer base. Management expects continued growth and increased design wins, with AI infrastructure demand strengthening.

$ALABHighAI 8/10

Northland upgrades Astera Labs stock rating on strong quarter

Northland upgraded Astera Labs (ALAB) to Outperform with a $315 price target, citing strong Q3 results and raised guidance. The Scorpio switch family exceeded $1B annual run rate, driving 98% revenue growth over the last year. Despite a 21% stock drop, ALAB trades above Fair Value. Other analysts lowered price targets due to valuation concerns.

$ALABMedAI 8/10

Needham cuts Astera Labs stock price target on AI sector valuation

Needham reduced its price target for Astera Labs (ALAB) to $300 from $425, citing AI sector valuation pressures, despite raising its estimates. ALAB's stock fell 21% in a week and is deemed overvalued by InvestingPro's Fair Value calculation. The company reported strong Q3 2026 results, with revenue up 98% YoY to $1.2B, and raised guidance. UBS also cut its target to $290 but raised revenue and earnings forecasts through 2028.

$ALABHighAI 8/10

Astera Labs Stock Rises After Revenue Jumps 154%

Astera Labs (ALAB) reported Q3 revenue of $584.9M, up 154% YoY, beating estimates. Non-GAAP EPS was $1.32 vs. $1.19 expected. Non-GAAP operating margin widened to 44.7%, but gross margin slipped to 72.4%. Q4 guidance: revenue $730M-$750M, non-GAAP EPS $1.62-$1.66. Inventory rose to $200.9M.